Health Tech Daily Brief - September 21, 2026

newsGP - Ageing, chronic illness, and AI: What the next 40 years mean for GPs

  Royal Australian College of General Practitioners (RACGP)

Law Pod UK latest episode: AI in healthcare

AI scans pathology slides to predict pancreatic cancer recurrence

Veterinary Telemedicine Market to Reach US$337.3 Million by 2033 at 9.8% CAGR | Persistence Market Research

Telehealth, in-home care expanding in Cadillac

Greek Hospital Tests Telemedicine and AI in Emergency Care

Chronic disease surge to push remote patient monitoring market to $62.2b

Your Body Is the Product - Why Wearables Investors Have Stopped Caring About the Device

I wore the Ultrahuman Ring Pro for a month, and it gave me more health data than I knew what to do with

HealthOne central rollout gathering steam

What 2.7 million patient visits a week reveal about the next decade of AI in clinical work

RFK Jr. Overhauls USPSTF Leadership: 5 Things to Know

HHS Secretary Robert F. Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force this week, completing the 16-seat panel amid ongoing tension over its leadership. The post RFK Jr. Overhauls USPSTF Leadership: 5 Things to Know appeared first on MedCity News.

Tomatosystem hits daily limit up on US insurer CMS approval; insurtech business enters full swing

Tomato System soars as U.S. partner wins CMS nod, eyes insurtech push - CHOSUNBIZ

UK startup snares $20m to recreate gigs with ‘hyper-realistic’ digital avatars

Electra’s Upsized IPO Lands $350M for New Class of Precision Immunology Drugs

Electra Therapeutics’ IPO cash will support a potential first-in-class drug whose lead indication is a rare hyperinflammatory disorder with no FDA-approved treatments. Meanwhile, clinical-stage biotechs Marea Therapeutics and Sensorion revealed their respective plans to enter the U.S. public markets. The post Electra’s Upsized IPO Lands $350M for New Class of Precision Immunology Drugs appe…

Angle Health Raises $600M to Grow Employer Health Benefits Platform

Angle Health’s funding round was led by Vitruvian Partners, with participation from Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital and Y Combinator. The post Angle Health Raises $600M to Grow Employer Health Benefits Platform appeared first on MedCity News.

Talking to a chatbot ‘therapist’? Know your risks